Goserelin mcetate, Purity ≥98%

Synonym: 145781-92-6; ICI118630; ICI-118630; ICI 118630; Acetic acid; (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

MDL: MFCD01747329
CAS Number: 145781-92-6
Compound CID: 16052011

Product Size

5 mg; 10 mg; 20 mg; 50 mg

Price

Datasheet

MSDS

Properties

Description

Goserelin mcetate, soluble in water, is a synthetic decapeptide analog. The molecular weight of the compound is 1329.49, and its molecular formula is C₆₁H₈₈N₁₈O₁₆.

Molecular Weight

1329.49

Molecular Formula

C₆₁H₈₈N₁₈O₁₆

Form

Lyophilized powder

Purity

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: Water: 99 mg/mL (74.46 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

Goserelin mcetate can be studied extensively for its potential therapeutic applications in the treatment of hormone-sensitive cancers, such as prostate cancer and breast cancer, as well as conditions like endometriosis and uterine fibroids.